Comirnaty Generic Name & Formulations
Legal Class
General Description
Pharmacological Class
How Supplied
Single-dose vials, prefilled syringes—1, 10
Manufacturer
Generic Availability
Mechanism of Action
Comirnaty Indications
Indications
Active immunization to prevent COVID-19.
Comirnaty Dosage and Administration
Adults and Children
<12yrs: not established. Give by IM inj only. ≥12yrs: 0.3mL as a single dose. Previously vaccinated with any COVID-19 vaccine: give dose at least 2 months after the last dose.
Administration
Visually inspect parenteral drug products for particulate matter and discoloration prior to administration. The vaccine will be a white to white-off suspension.
Administer the 0.3mL dose intramuscularly immediately after preparation. For the prefilled syringe, administer entire volume to deliver a single 0.3mL dose.
Comirnaty Contraindications
Not Applicable
Comirnaty Boxed Warnings
Not Applicable
Comirnaty Warnings/Precautions
Warnings/Precautions
Have epinephrine inj available. Increased risks of myocarditis and pericarditis (esp. within 7 days after vaccination); highest among males 12–17yrs of age. Syncope. Immunocompromised. Pregnancy. Nursing mothers.
Comirnaty Pharmacokinetics
See Literature
Comirnaty Interactions
Interactions
Comirnaty Adverse Reactions
Adverse Reactions
Comirnaty Clinical Trials
Comirnaty Note
Not Applicable